Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Epitope Studies with Anti-β2-glycoprotein I Antibodies from Autoantibody and Immunized Sources. Local targets link to admitted publications; unresolved targets remain external evidence.
Immunology and clinical importance of antiphospholipid antibodies
10.1016/s0065-2776(08)60777-4 · 1991 · External reference
Current insights into the ‘antiphospholipid’ syndrome: clinical, immunological, and molecular aspects
10.1016/s0065-2776(08)60393-4 · 1998 · External reference
The methodology and clinical significance of anticardiolipin antibodies
10.1128/cdli.6.6.775-782.1999 · 1999 · External reference
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H)
10.1073/pnas.87.11.4120 · 1990 · External reference
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
10.1016/0140-6736(90)91374-j · 1990 · External reference
Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface
10.1084/jem.179.2.457 · 1994 · External reference
‘Anticardiolipin’ autoantibodies recognize β2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding
10.4049/jimmunol.154.2.954 · 1995 · External reference
Site-directed mutagenesis of recombinant human β2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity
10.4049/jimmunol.157.8.3744 · 1996 · External reference
Epitope specificity of monoclonal anti-β2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome
10.4049/jimmunol.155.3.1629 · 1995 · External reference
Human β2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system
10.1182/blood.v87.8.3262.bloodjournal8783262 · 1996 · External reference
Target recognition of β2-glycoprotein I (β2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of β2GPI in antibody binding
10.4049/jimmunol.160.8.3917 · 1998 · External reference
Anti-β2-glycoprotein I (B2GPI) autoantibodies recognize an epitope on the first domain of β2GPI
10.1073/pnas.95.26.15542 · 1998 · External reference
Heterogeneity and immunochemical properties of anti-β2-glycoprotein I autoantibodies
10.1055/s-0037-1615218 · 1998 · External reference
Anti-β2-glycoprotein I autoantibodies from patients with the ‘antiphospholipid’ syndrome bind to β2-glycoprotein I with low affinity: dimerization of β2-glycoprotein I induces a significant increase in anti-β2-glycoprotein I antibody affinity
10.4049/jimmunol.161.4.2038 · 1998 · External reference
Immunization of a rabbit with β2-glycoprotein I induces a charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies
10.4049/jimmunol.155.2.958 · 1995 · External reference
Monoclonal antibodies from NZW×BXSB F1 mice to β2-glycoprotein I and cardiolipin. Species specificity and charge-dependent binding
10.4049/jimmunol.156.7.2631 · 1996 · External reference
Heterogenous recognition of β2-glycoprotein I by antibodies from antiphospholipid syndrome patients
10.1055/s-0037-1614031 · 2000 · External reference
Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface
10.1055/s-0038-1653721 · 1995 · External reference
Binding properties of antibodies to prothrombin and β2-glycoprotein I (β2GPI) assayed by ELISA and dot blot
10.1046/j.1365-2249.1999.01064.x · 1999 · External reference
The anti-β2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species' evolution
10.4049/jimmunol.157.12.5732 · 1996 · External reference
Role of divalency in the high-affinity binding of anticardiolipin antibody-β2-glycoprotein I complexes to lipid membranes
10.1021/bi960657q · 1996 · External reference
Conformationally altered β2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies
10.1046/j.1365-2249.1999.00810.x · 1999 · External reference
Some ‘antiphospholipid antibodies’ bind to β2-glycoprotein I in the absence of phospholipid
10.1111/j.1365-2141.1992.tb06469.x · 1992 · External reference
Anti-β2-glycoprotein I antibodies: detection and association with thrombosis
10.1111/j.1365-2141.1995.tb03317.x · 1995 · External reference
Modification of β2-glycoprotein I by glutardialdehyde. Conformational changes and aggregation accompany exposure of the cryptic autoepitope
10.1385/abab:76:1:1 · 1999 · External reference